AU9297798A - Substituted 1,2,4-triazoles useful for inhibiting cholesteryl ester transfer protein activity - Google Patents
Substituted 1,2,4-triazoles useful for inhibiting cholesteryl ester transfer protein activityInfo
- Publication number
- AU9297798A AU9297798A AU92977/98A AU9297798A AU9297798A AU 9297798 A AU9297798 A AU 9297798A AU 92977/98 A AU92977/98 A AU 92977/98A AU 9297798 A AU9297798 A AU 9297798A AU 9297798 A AU9297798 A AU 9297798A
- Authority
- AU
- Australia
- Prior art keywords
- substituted
- protein activity
- transfer protein
- cholesteryl ester
- ester transfer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000000178 1,2,4-triazoles Chemical class 0.000 title 1
- 102000012336 Cholesterol Ester Transfer Proteins Human genes 0.000 title 1
- 108010061846 Cholesterol Ester Transfer Proteins Proteins 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 230000004952 protein activity Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5901897P | 1997-09-16 | 1997-09-16 | |
| US60059018 | 1997-09-16 | ||
| PCT/US1998/018170 WO1999014204A1 (en) | 1997-09-16 | 1998-09-14 | Substituted 1,2,4-triazoles useful for inhibiting cholesteryl ester transfer protein activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU9297798A true AU9297798A (en) | 1999-04-05 |
Family
ID=22020294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU92977/98A Abandoned AU9297798A (en) | 1997-09-16 | 1998-09-14 | Substituted 1,2,4-triazoles useful for inhibiting cholesteryl ester transfer protein activity |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU9297798A (en) |
| WO (1) | WO1999014204A1 (en) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6642268B2 (en) | 1994-09-13 | 2003-11-04 | G.D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors |
| JP2894445B2 (en) * | 1997-02-12 | 1999-05-24 | 日本たばこ産業株式会社 | Compounds effective as CETP activity inhibitors |
| KR20010099937A (en) * | 1998-12-23 | 2001-11-09 | 윌리암스 로저 에이 | Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications |
| EA005815B1 (en) * | 1998-12-23 | 2005-06-30 | Джи.Ди.Сирл Ллс | Combinations od ileal bile acid transport inhibitors and cholesteryl transfer protein inhibitors for cardiovascular indications |
| DE69908643T2 (en) * | 1998-12-23 | 2004-05-13 | G.D. Searle Llc, Chicago | COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND NICOTIC ACID DERIVATIVES FOR CARDIOVASCULAR INDICATIONS |
| EP1340510A1 (en) * | 1998-12-23 | 2003-09-03 | G.D. Searle LLC. | Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications |
| US6451823B1 (en) | 1999-09-23 | 2002-09-17 | G.D. Searle & Co. | Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| US6677341B2 (en) | 1999-09-23 | 2004-01-13 | Pharmacia Corporation | (R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| US6677382B1 (en) | 1999-09-23 | 2004-01-13 | Pharmacia Corporation | Substituted N,N-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| US20010018446A1 (en) | 1999-09-23 | 2001-08-30 | G.D. Searle & Co. | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| US7115279B2 (en) | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| IL158765A0 (en) * | 2001-06-21 | 2004-05-12 | Pfizer Prod Inc | Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| CA2450957A1 (en) * | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| WO2003000238A1 (en) | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drug |
| EP1269994A3 (en) | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| JP2005521653A (en) | 2002-01-17 | 2005-07-21 | ファルマシア コーポレイション | Novel alkyl / arylhydroxy or ketothiepine compounds as inhibitors of advanced sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| BR0307344A (en) | 2002-02-01 | 2004-12-14 | Pfizer Prod Inc | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase forming materials |
| AR038375A1 (en) | 2002-02-01 | 2005-01-12 | Pfizer Prod Inc | PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE PROTEIN OF TRANSFER OF ESTERES DE COLESTERILO |
| DE60322680D1 (en) | 2002-02-07 | 2008-09-18 | Univ Missouri | OPIOID RECEPTOR ACTIVES 4- (3-HYDROXYPHENYL) OR 4- (3-ALKOXYPHENYL) -1,2,4-TRIAZOL COMPOUNDS |
| AR039385A1 (en) | 2002-04-19 | 2005-02-16 | Astrazeneca Ab | THIOXANTINE DERIVATIVES AS INHIBITORS OF MIELOPEROXIDASA |
| EP1578415B1 (en) | 2002-12-20 | 2008-09-10 | Pfizer Products Inc. | Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor |
| US7276536B2 (en) | 2003-03-17 | 2007-10-02 | Japan Tobacco Inc. | Method for increasing the bioavailability of the active form of S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino) phenyl] 2-methylpropanethioate |
| ATE534381T1 (en) | 2003-03-17 | 2011-12-15 | Japan Tobacco Inc | PHARMACEUTICAL CETP INHIBITOR COMPOSITIONS |
| CL2004001884A1 (en) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | DRYING PROCEDURE FOR SPRAYING FOR THE FORMATION OF SOLID DISPERSIONS AMORPHES OF A PHARMACO AND POLYMERS. |
| BRPI0413277A (en) | 2003-08-04 | 2006-10-10 | Pfizer Prod Inc | pharmaceutical compositions of amorphous drug adsorbates and lipophilic microphase forming materials |
| CN1886124A (en) | 2003-09-26 | 2006-12-27 | 日本烟草产业株式会社 | Methods of inhibiting the production of residual lipoproteins |
| MY140748A (en) | 2004-12-06 | 2010-01-15 | Astrazeneca Ab | Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy |
| WO2006082518A1 (en) | 2005-02-03 | 2006-08-10 | Pfizer Products Inc. | Pharmaceutical compositions with enhanced performance |
| WO2006098394A1 (en) * | 2005-03-14 | 2006-09-21 | Japan Tobacco Inc. | Method for inhibiting lipid absorption and lipid absorption inhibitor |
| WO2007048027A2 (en) | 2005-10-21 | 2007-04-26 | Novartis Ag | Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent |
| TW200804383A (en) | 2006-06-05 | 2008-01-16 | Astrazeneca Ab | New compounds |
| US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| WO2014199164A1 (en) * | 2013-06-12 | 2014-12-18 | Ampla Pharmaceuticals, Inc. | Diaryl substituted heteroaromatic compounds |
| CA2968585C (en) | 2014-11-24 | 2022-11-01 | Lubrizol Advanced Materials, Inc. | Novel coupled uracil compound for vinyl chloride polymer resins |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3701784A (en) * | 1968-09-04 | 1972-10-31 | Rohm & Haas | 1,2,4-4h-triazole derivatives |
| FR2546887B1 (en) * | 1983-05-30 | 1985-08-30 | Paris 7 Universite | PROCESS FOR THE PREPARATION OF 2,4-DIHYDRO-TRIAZOL-1,2,4 THIONES-3 DISUBSTITUTED IN POSITIONS 4 AND 5 AND NOVEL COMPOUNDS THAT CAN BE PREPARED BY THIS PROCESS |
-
1998
- 1998-09-14 WO PCT/US1998/018170 patent/WO1999014204A1/en not_active Ceased
- 1998-09-14 AU AU92977/98A patent/AU9297798A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999014204A1 (en) | 1999-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU9297798A (en) | Substituted 1,2,4-triazoles useful for inhibiting cholesteryl ester transfer protein activity | |
| AU3285499A (en) | Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity | |
| AU4073997A (en) | 1,4-heterocyclic metallprotease inhibitors | |
| AU5236698A (en) | General access system | |
| AU7181798A (en) | Merchandizing system | |
| AU8497898A (en) | Order pick system | |
| AU1699797A (en) | Tangle-resistant leash | |
| AU6161099A (en) | Substituted n-aliphatic-n-aromatic (tertiary)-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | |
| AU1559199A (en) | Isothiazolcarboxylic acid derivatives | |
| AU3340797A (en) | Modified oligonucleotides | |
| AU9066598A (en) | Substituted 4-benzoyl-pyrazoles | |
| AU7476598A (en) | 18-substituted-19-nor-vitamin d compounds | |
| AU5208598A (en) | Computer kiosk | |
| AU5345798A (en) | Fructan-polycarboxylic acid | |
| AU6090898A (en) | Substituted 4-benzoyl-pyrazoles | |
| AUPP003297A0 (en) | 4,5-diaryloxazole compounds | |
| AU2638597A (en) | Access control system | |
| AU6900598A (en) | Record system | |
| AU5779598A (en) | Triazole derivatives | |
| AU7530198A (en) | Substituted 4-benzoyl-pyrazoles | |
| AU2696897A (en) | Modified oligonucleotides | |
| AU7212698A (en) | Substituted aryluracils | |
| AUPP029797A0 (en) | Modifications for improved biological response 2 | |
| AUPP029897A0 (en) | Modifications for improved biological response 3 | |
| AU2738397A (en) | Heterocyclic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |